VulnerabilityModified
CVE-2018-16148
The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.
MEDIUM 6.1EPSS 1.31%
Does this matter?
Lower severity and a low EPSS score (1.31%). Track it; it rarely justifies an emergency change on its own.
Description
The diagnosticsb2ksy parameter of the /rest endpoint in Opsview Monitor before 5.3.1 and 5.4.x before 5.4.2 is vulnerable to Cross-Site Scripting.
- CVSS 3.0
- 6.1 MEDIUMCVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 1.31% probability · 69th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- opsview/opsview
- Source
- cve@mitre.org
References
- https://knowledge.opsview.com/v5.3/docs/whats-newRelease Notes, Vendor Advisory
- https://knowledge.opsview.com/v5.4/docs/whats-newRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2018/Sep/3Exploit, Mailing List, Third Party Advisory
- https://www.coresecurity.com/advisories/opsview-monitor-multiple-vulnerabilitiesExploit, Third Party Advisory
- https://knowledge.opsview.com/v5.3/docs/whats-newRelease Notes, Vendor Advisory
- https://knowledge.opsview.com/v5.4/docs/whats-newRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2018/Sep/3Exploit, Mailing List, Third Party Advisory
- https://www.coresecurity.com/advisories/opsview-monitor-multiple-vulnerabilitiesExploit, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.